Beckman Coulter's Q2 Revenues Jump 15.7 Percent on Strong Dx Sales | GenomeWeb
NEW YORK (GenomeWeb News) – Beckman Coulter today reported that its second-quarter revenues increased 15.7 percent, or 11.2 percent excluding currency translation effects, driven by 17.1 percent growth in its clinical diagnostics business.
The Orange County, Calif.-based firm brought in total revenues of $798.3 million for the three-month period ended June 30, compared to revenues of $689.7 million for the second quarter of 2007.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.